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Kory J. Lavine, MD, PHD,a,b Joel D. Schilling, MD, PHDa,c,dSEE PAGE 155T he heart failure literature is ﬁlled with agrowing body of research that has identiﬁedan array of signaling pathways, transcription
factors, noncoding ribonucleic acids (micro- and long
noncoding ribonucleic acids), and genetic variants
that are associated with either the presence and/or
severity of heart failure. Although these ﬁndings
often constitute important and seminal observations,
such studies are limited in that they are essentially
hypothesis-generating and do not establish causal
relationships. Moreover, it remains challenging to
dissect the mechanistic elements that ultimately
govern how a particular molecule exerts its effects
on the human myocardium. Most investigators have
turned to rodent models to address these issues; how-
ever, it has become apparent that vast differences
exist between human and model organisms (1,2).
In an effort to overcome these limitations,
numerous investigators have attempted to establish
primary human ventricular cardiomyocyte prepara-
tions that are suitable for cell culture and in vitro
studies (3). Unfortunately, these systems are hin-
dered by poor cardiomyocyte viability, inability to*Editorials published in JACC: Basic to Translational Science reﬂect the
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Center (P30DK052574), and DiaComp (DK076169).culture cells for a prolonged period of time, limited
transfection efﬁciency, and a wide range of experi-
mental variability (4). More recently, substantial
attention has focused on the development of car-
diomyocyte systems derived from human embryonic
stem cells and induced pluripotent stem cells. These
types of cardiomyocytes can be cultured for indeﬁnite
periods of time and seem to constitute a promising
approach to understand the functional impact of
genetic variants; these approaches are limited, how-
ever, by the realization that these cells are immature
and most closely resemble embryonic cardiomyocytes
(5,6). Moreover, each of these cell culture–based
systems is confounded by the notion that cultured
cardiomyocytes are being studied out of their native
context. Speciﬁcally, these systems ignore important
contributions from extracellular matrix elements and
supporting cells such as ﬁbroblasts, endothelial cells,
and resident immune cells.The limitation of adequate experimental ap-
proaches has imposed an enormous challenge on
investigators engaged in human translational car-
diovascular biology: how can one establish causal
links and deﬁne relevant molecular mechanisms in
human systems? In this issue of JACC: Basic to
Translational Science, Thomas et al. (7) offer an
innovative and promising solution. Using a slice cul-
ture base system, they show that 250-mm slices
of human ventricular myocardium can be readily
obtained from patients with heart failure and remain
viable in culture for at least 3 days. To highlight the
versatility of this system, the investigators present
evidence that human myocardial slice preparations
are suitable for cell signaling, mechanical trans-
duction, and viral transfection experiments. As proof
of principle, they reveal for the ﬁrst time that the
alpha1-adrenergic signaling pathway is functional in
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169the human adult myocardium and in this context
serves as a positive regulator of muscle contraction.
This paper (7) builds on a body of research that has
used slice culture systems for the study of human
brain, liver, and kidney physiology and pathology.
Within these contexts, slice culture preparations have
served as invaluable resources to investigate tissue
responses to infection, pharmaceutical agents, envi-
ronmental toxins, and molecular pathways that
govern tissue ﬁbrosis (8,9). A central advantage of
tissue slices is that they elegantly preserve many
aspects of tissue architecture, including cellular
orientation, intercellular connections, and extracel-
lular matrix elements. Moreover, these systems not
only allow interrogation of signaling events within
cells but also the ability to identify signaling events
that mediate interactions between diverse tissue-
resident cell types.
Although the ﬁndings of Thomas et al. (7) have
provided a potentially exciting avenue to approach
human translational cardiovascular biology with a
more mechanistic mindset, it is likely that substantial
research remains to better reﬁne human heart slice
culture systems and more adequately deﬁne their
limitations. Future studies will ultimately be required
to decipher the optimal conditions for slice prepara-
tion, determine the duration that slices can becultured, and deﬁne the range of variability seen
within and between specimens. To date, there are few
reports of human heart slice culture (10–12). One
group used septal myectomy specimens and a
different slicing apparatus (10). Intriguingly, they
reported that slices could survive for up to 4 weeks in
culture, albeit with altered tissue morphology. As
more investigators adopt slice culture systems, the
strengths, weaknesses, and optimal uses of these
preparations will be better deﬁned, including adap-
tation of culture conditions that most closely
resemble endogenous myocardial tissue.
Most importantly, the continued development of
experimental systems to study human cardiac biology
will ultimately provide the missing link necessary to
establish the requisite causal relationships and mo-
lecular mechanisms that underlie the pathogenesis of
human cardiac disease. Such insights will be essential
to efﬁciently and successfully develop novel thera-
pies that could ultimately be translated into clinical
practice.
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